Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer across PD-L1 expression levels and subtypes, highlighting its potential to set a new standard of care Pumitamig plus chemotherapy

New Earth Resources Announces Private Placement

Vancouver, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) — NEW EARTH RESOURCES CORP. (CSE: EATH) (“New Earth” or the “Company“) is pleased to announce that it will be conducting a non-brokered

A New Chapter Is Emerging in Pakistan-China Relations

ISLAMABAD, May 30, 2026 (GLOBE NEWSWIRE) — The Ministry of Information and Broadcasting (MoIB) is responsible for promoting and managing the official narrative surrounding Prime Minister Shehbaz Sharif’s visit to

Scroll to Top